Revenue

With a new $19 entry-level plan and a scalable ecosystem, MioCommerce is making a strategic play to equip service businesses from solo startups to large teams.

With a history of strong growth, Jefferson Capital's upcoming earnings are a key indicator for investors and the consumer debt market. Will it deliver?

MPS smashes Q1 revenue records, fueled by a 98% surge in its AI data segment. The company now eyes a massive $6 billion capacity expansion.

With record growth and raised guidance, the REIT leverages market trends and strategic partnerships to solidify its leadership in medical real estate.

Amid a Q2 net loss driven by rising mortgage rates and geopolitical tension, Beazer Homes accelerates share repurchases, signaling confidence in its strategy.

A new program offers local manufacturers integrated financial, strategic, and PR support at a fraction of the cost, aiming to boost a key regional industry.

Contineum Therapeutics reports encouraging early data for its non-opioid drug PIPE-791, offering a potential new weapon in the fight against chronic pain.

Bain-backed Archwest Capital surpasses $2.5B in funding and poaches top talent, intensifying competition in the private real estate lending market.

Following a record-breaking quarter, Enova's executives will detail their AI-powered growth engine and future outlook at the Needham investor conference.

Aimco declares a $1.30/share liquidating distribution. Understand the 'due bills' trading and what this means for your investment as the REIT winds down.

Singapore oil trader Delixy Holdings reports a $4.5M loss despite record volume, betting big on a costly diversification into the LNG and LPG markets.

A massive data expansion is giving investors unprecedented visibility into smaller senior housing markets just as demographic demand surges to historic highs.

UBS lands 34 teams on Forbes' 2026 list for SoCal & Hawaii, revealing a strategy of deep regional expertise and the future of personalized financial advice.

With a new CEO who helped build Liquid Death, A-GAME Beverages is betting his CPG playbook can turn the athlete-backed brand into a national powerhouse.

HFCL posts record profits and a $2.36B order book, fueled by a major push into the defense sector and a massive increase in international sales.

The Mather Group's partnership with Sebold Capital highlights a key industry trend: acquiring deep expertise to serve the integrated needs of entrepreneurs.

Activist investor Trian Fund Management launches a public campaign against Solventum, alleging massive value destruction and excessive executive compensation.

LCL and Crédit Agricole Assurances finalize the acquisition of Milleis Group, a strategic move to dominate France's affluent client market.

Despite a 19% revenue jump amidst Greece's record tourism year, hotel group The Azur Selection posts a €5.7M loss, triggering a 'going concern' warning.

Biotech firm Ocubio adds commercial titan Jim Mazzo and clinical pioneer Dr. Eric Donnenfeld, signaling a major play to disrupt the ocular health market.